ENDECE

Endece is a privately held biopharmaceutical company at the forefront of new discovery and development. Our library of proprietary compounds, invented and owned by ENDECE, was designed to stop disease by regulating specific biological pathways to stimulate a biological response for a gain of function. we focus on diseases whose treatment options are limited or non-existent, whose causes may not be well understood and whose clinical development paths are still undefined including multiple sclerosis (MS) and Alzheimer's disease.